UiPath (NYSE:PATH) closed the Independence Day holiday-shortened week at $11.71, marking an 11.2% gain from the prior Friday's close of $10.53. The rally outpaced major tech ETFs, including the iShares Expanded Tech-Software Sector ETF (IGV), which rose 6.1%, and the Invesco QQQ Trust (QQQ), which gained 0.9% over the same period. The New York Stock Exchange and Nasdaq were closed on July 3 for the holiday.
Short Interest and Volume Dynamics
Short interest in UiPath stood at 126.25 million shares as of June 15, representing 32.23% of the float, according to MarketWatch. This elevated short position, valued at approximately $1.48 billion at Thursday's close, created conditions for a potential squeeze. Trading volume surged to 58.4 million shares on July 2, or 153% of the 65-day average volume of 38.23 million shares. With a days-to-cover ratio of 3.3 at the 65-day pace, the stock remains vulnerable to further short covering if buying momentum continues when U.S. markets reopen Monday.
Buyback Program and Financial Position
UiPath has been actively repurchasing shares, completing a $1 billion buyback in March and authorizing a new $500 million program. In the first quarter ended April 30, the company bought back $243.8 million of Class A shares. As of that date, UiPath held $1.42 billion in cash, cash equivalents, and marketable securities, down from $1.69 billion at January 31. The buyback pace in Q1 was nearly 1.85 times operating cash flow of $131.9 million, underscoring the company's commitment to returning capital to shareholders.
Q2 Guidance and ARR Outlook
UiPath's Q1 results showed revenue of $418 million, up 17% year-over-year, with annual recurring revenue (ARR) reaching $1.901 billion, a 12% increase. However, the Q2 outlook projects revenue between $395 million and $400 million, with ARR expected to range from $1.929 billion to $1.934 billion. This implies net new ARR of $28 million to $33 million, a significant deceleration from the $49 million added in Q1. Non-GAAP operating income is forecast at approximately $75 million, down from $92 million in Q1.
Management Commentary and Analyst Views
CEO Daniel Dines noted that the company's agentic products are transitioning from pilot to production phases. CFO Ashim Gupta highlighted Q1 as the first quarter of GAAP profitability, with results exceeding guidance. Analysts remain cautious, with a consensus price target of $14.43 from 22 analysts, according to Benzinga. Recent ratings from UBS, BMO Capital, and DA Davidson average $12.33, about 6% above the current price.
Upcoming Catalysts
FINRA is scheduled to publish updated short interest data as of June 30 on July 10, which will not capture the full extent of the July 1-2 rally. No major company events are on the immediate calendar, leaving the stock's near-term direction tied to trading dynamics and potential short covering.
